Preoperative Anxiety and One-year Patient-reported Outcomes in Orthopedic Surgery Patients Receiving Enhanced Recovery After Surgery or Conventional Care (ERAS-APO)
A Prospective Cohort Study Comparing Preoperative Anxiety and One-Year Patient-Reported Outcomes Between Enhanced Recovery After Surgery and Conventional Care in Orthopedic Surgery Patients
This study investigates whether an Enhanced Recovery After Surgery (ERAS) program can help orthopedic surgery patients feel less anxious before their operation and recover better one year after surgery, compared to conventional (standard) surgical care.
Patients who undergo orthopedic surgery, such as joint replacement, often experience significant anxiety before the operation. While ERAS programs, which combine patient education, pain management, and early mobilization, have been shown to shorten hospital stays and reduce complications, less is known about whether they also reduce preoperative anxiety and lead to better long-term outcomes reported by patients themselves.
In this prospective cohort study, patients receiving ERAS care will be compared with patients receiving conventional care. Preoperative anxiety will be measured using a validated questionnaire (APAIS). Clinical recovery during hospitalization, including length of stay, pain scores, and opioid use, will also be recorded. Patients will then be followed for one year to assess their quality of life (EQ-5D-5L) and their own impression of overall improvement (Patient Global Impression of Change).
The goal of this study is to determine whether ERAS not only improves short-term surgical recovery, but also reduces preoperative anxiety and leads to better long-term, patient-centered outcomes.
調査の概要
状態
条件
詳細な説明
This is a prospective, observer-blinded cohort study conducted at Hualien Tzu Chi Hospital, comparing patients who receive Enhanced Recovery After Surgery (ERAS) care with those who receive conventional perioperative care for orthopedic surgery.
Group assignment (ERAS vs. conventional care) follows the clinical care pathway naturally selected by the treating surgical team according to institutional standard practice; the study team does not intervene in treatment decisions and functions solely as an independent, blinded outcome assessor.
The ERAS pathway includes multiple evidence-based components delivered as part of routine institutional care: preoperative patient education and expectation management, shortened fasting time with preoperative carbohydrate loading, multimodal analgesia and antiemetic strategies, standardized timing for drain/catheter removal, and early postoperative mobilization with structured discharge planning. Patients in the conventional care group receive the hospital's existing standard perioperative management.
Preoperative anxiety is assessed at two time points using the Amsterdam Preoperative Anxiety and Information Scale (APAIS): a baseline measurement immediately after the patient provides informed consent for surgery, prior to any ERAS or conventional preoperative education (T0), and a follow-up measurement after hospital admission, following completion of preoperative education (ERAS or conventional), immediately before the patient enters the operating room (T1). This pre-post design allows the study to evaluate the within-subject change in anxiety attributable to the preoperative care pathway, in addition to between-group comparisons at each time point.
In-hospital clinical recovery is tracked at multiple postoperative time points (24, 48, and 72 hours, and at discharge), including length of hospital stay, postoperative opioid consumption, pain scores (NRS), time to first mobilization and ambulation, and time to catheter/drain removal.
Patients are followed for one year after surgery to assess patient-reported outcomes, including health-related quality of life (EQ-5D-5L) and the Patient Global Impression of Change (PGIC), in order to evaluate whether differences observed in preoperative psychological status and short-term clinical recovery translate into sustained, patient-centered benefits over the long term.
Given the non-randomized, naturalistic allocation of patients to care pathways, statistical analyses will account for baseline differences between groups using multivariable adjustment and generalized estimating equations (GEE) for repeated measures over time.
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前:Jing-Ru Wu, MSN, RN;PhD Student
- 電話番号:+886-922095954
- メール:113330117@gms.tcu.edu.tw
研究場所
-
-
Hualien County
-
Hualien City、Hualien County、台湾、970
- 募集
- Hualien Tzu Chi Hospital
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
The study population consists of hospitalized patients aged 20 years or older who are scheduled for elective major orthopedic surgery (such as total knee arthroplasty, total hip arthroplasty, or spinal surgery) at Hualien Tzu Chi Hospital.
説明
Inclusion Criteria:
-
Inclusion Criteria:
- Age >= 20 years.
- Hospitalized patients scheduled for elective major orthopedic surgery (such as total knee arthroplasty, total hip arthroplasty, or spinal surgery).
- Possess sufficient language comprehension and expression skills to complete interviews and questionnaires in Mandarin, Taiwanese, Hakka, or English.
- Agree to participate in the study and provide written informed consent.
Exclusion Criteria:
- Patients requiring immediate management due to emergency or traumatic urgent surgery.
- Diagnosed by a physician with significant cognitive impairment, delirium, or severe mental illness resulting in the inability to complete evaluation and follow-up.
- Severe and unstable medical conditions (such as ASA-V, shock, or requiring long-term intensive care treatment).
- Anticipated requirement for intensive care unit (ICU) admission postoperatively.
- Concurrent participation in other clinical trials or intervention studies that would affect anxiety or functional outcomes.
- Patients for whom follow-up up to 12 months is inconvenient or difficult during the study period.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:COHORT
- 時間の展望:PROSPECTIVE
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
ERAS group
Participants who selected the ERAS-based preoperative optimization pathway as part of routine clinical care after receiving information about the available perioperative care pathways from their treating surgical team. The research team did not participate in the selection of the clinical care pathway. |
A standardized, multidisciplinary perioperative care pathway including standardized preoperative education, nutrition and fasting optimization (shortened fasting time with preoperative carbohydrate drinks), multimodal anesthesia and analgesia (prioritizing non-opioid medications and nerve blocks), and early mobilization (encouraging mobilization within hours postoperatively, early oral intake, and early catheter removal). |
|
Conventional care group
Participants who selected conventional care as part of routine clinical care after receiving information about the available perioperative care pathways from their treating surgical team. The research team did not participate in the selection of the clinical care pathway. |
Routine perioperative clinical care based on conventional medical orders. It primarily includes conventional routing education, strict fasting from midnight before surgery, and reliance on opioid medications via patient-controlled analgesia (PCA) as the primary method for postoperative pain management. Postoperative mobilization and oral intake are guided later based on patient tolerance and routine medical orders. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Preoperative Anxiety (APAIS Score)
時間枠:Approximately 1 week before surgery (T0) and on the day of surgery, immediately before induction of anesthesia (T1)
|
Preoperative anxiety level measured using the Amsterdam Preoperative Anxiety and Information Scale (APAIS) anxiety subscale, which ranges from 4 to 20. Higher scores indicate higher levels of anxiety. |
Approximately 1 week before surgery (T0) and on the day of surgery, immediately before induction of anesthesia (T1)
|
|
1-Year Patient-Reported Quality of Life (EQ-5D-5L Index)
時間枠:At 12 months postoperatively.
|
Long-term health-related quality of life evaluated using the EQ-5D-5L traditional Chinese version for Taiwan. The utility index will be calculated to assess patient-reported outcomes. The EQ-5D-5L utility index ranges from -0.016 to 1, where higher scores indicate a better health-related quality of life. |
At 12 months postoperatively.
|
|
EQ-VAS Self-Rated Health Score
時間枠:At 3, 6, 9, and 12 months after surgery
|
Participant's self-rated health on the EQ-5D visual analogue scale (EQ-VAS), a vertical scale from 0 (worst health imaginable) to 100 (best health imaginable). Higher scores indicate better self-rated health. |
At 3, 6, 9, and 12 months after surgery
|
|
Time to First Out-of-Bed Mobilization
時間枠:End of surgery is defined as completion of wound closure; time is rounded to the nearest hour.
|
Time from the end of surgery to the first time the participant stands with both feet on the floor and leaves the bed, recorded in hours. Shorter times indicate earlier mobilization. |
End of surgery is defined as completion of wound closure; time is rounded to the nearest hour.
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Unplanned Hospital Readmission Within 90 Days
時間枠:Within 90 days after surgery
|
Number of participants with an unplanned hospital readmission within 90 days after surgery, as documented in the medical record. Time Frame: Within 90 days after surgery |
Within 90 days after surgery
|
|
Patient Global Impression of Change (PGIC)
時間枠:At 3, 6, 9, and 12 months after surgery
|
Participant-rated overall change in condition since surgery on the 7-point Patient Global Impression of Change (PGIC) scale: 1 = very much improved, 2 = much improved, 3 = minimally improved, 4 = no change, 5 = minimally worse, 6 = much worse, 7 = very much worse. Lower scores indicate greater improvement. |
At 3, 6, 9, and 12 months after surgery
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Length of Hospital Stay (LOS)
時間枠:From the day of surgery to hospital discharge (average of 3-7 days).
|
The total number of days spent in the hospital, calculated from the date of surgery to the date of discharge. |
From the day of surgery to hospital discharge (average of 3-7 days).
|
|
Incidence of Postoperative Complications
時間枠:Within 90 days after surgery
|
Number of participants with at least one postoperative complication, defined as any of the following: deep vein thrombosis, surgical site infection, prosthetic dislocation, hematoma, wound dehiscence, periprosthetic joint infection, or other complications documented in the medical record. Each complication is recorded as present (yes) or absent (no) for each participant. Participants with one or more complications are counted once. Individual complication types will also be reported descriptively. Time Frame: Within 90 days after surgery |
Within 90 days after surgery
|
|
Time to Foley Catheter Removal
時間枠:From the end of surgery until catheter removal during the hospital stay
|
Time from the end of surgery (completion of wound closure) to removal of the indwelling urinary (Foley) catheter, as documented in the nursing record, measured in hours and rounded to the nearest hour. Participants in whom no catheter was placed are recorded as 0 hours. Shorter times indicate earlier catheter removal. |
From the end of surgery until catheter removal during the hospital stay
|
|
Time to Surgical Drain Removal
時間枠:From the end of surgery until drain removal during the hospital stay
|
Time from the end of surgery (completion of wound closure) to removal of the surgical wound drain, as documented in the nursing record, measured in hours and rounded to the nearest hour. Participants in whom no drain was placed are recorded as 0 hours. Shorter times indicate earlier drain removal. |
From the end of surgery until drain removal during the hospital stay
|
|
Postoperative Pain Intensity (NRS)
時間枠:At 24, 48, and 72 hours after the end of surgery
|
Postoperative pain intensity at rest, rated by the participant on the 0-10 Numeric Rating Scale (NRS), where 0 = no pain and 10 = worst pain imaginable, taken from the routine ward pain assessment closest to each time point. Higher scores indicate greater pain. Scores are compared between groups at each time point. |
At 24, 48, and 72 hours after the end of surgery
|
|
Cumulative Postoperative Opioid Consumption
時間枠:From return to the ward after post-anesthesia care unit discharge until hospital discharge (an average of 5 days)
|
Total opioid analgesic consumption from return to the ward (discharge from the post-anesthesia care unit) until hospital discharge, excluding intraoperative and PACU administration. Opioids given (oral tramadol/acetaminophen [Tramacet], intramuscular morphine, and nalbuphine injection) are converted to oral morphine milligram equivalents (MME, mg) using standard conversion factors (tramadol x 0.2; parenteral morphine and nalbuphine x 3) and summed into a single cumulative value per participant. Lower values indicate less opioid use. |
From return to the ward after post-anesthesia care unit discharge until hospital discharge (an average of 5 days)
|
|
Lower-Extremity Muscle Strength (MMT Total Score)
時間枠:At 72 hours after surgery
|
Muscle strength of the operated limb assessed by Manual Muscle Testing (MMT). The hip, knee, and ankle are each graded 0-5 and summed into one total score (range 0-15). Higher scores indicate greater muscle strength. |
At 72 hours after surgery
|
|
Active Range of Motion of the Operated Joint
時間枠:At 72 hours after surgery
|
Active range of motion of the operated joint measured in degrees: hip flexion for total hip arthroplasty and knee flexion for total knee arthroplasty. Higher values indicate greater range of motion. |
At 72 hours after surgery
|
|
Patient Satisfaction
時間枠:At hospital discharge
|
Participant satisfaction with perioperative care rated on a 5-point scale: 1 = very dissatisfied, 2 = dissatisfied, 3 = neutral, 4 = satisfied, 5 = very satisfied. Higher scores indicate greater satisfaction. |
At hospital discharge
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- IRB114-217-B
- IRB114-217-B (その他の識別子:Institutional Review Board, Buddhist Tzu Chi General Hospital, Hualien)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Individual participant data will not be shared outside the research team to ensure strict data confidentiality and protection of personal privacy, as approved by the Institutional Review Board.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。